Influence of energy drink ingredients on mood and cognitive performance
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Sales of energy products have grown enormously in recent years. Manufacturers claim that the products, in the form of drinks, shots, supplements, and gels, enhance physical and cognitive performance, while users believe the products promote concentration, alertness, and fun. Most of these products contain caffeine, a mild psychostimulant, as their foremost active ingredient. However, they also contain additional ingredients, e.g., carbohydrates, amino acids, herbal extracts, vitamins, and minerals, often in unspecified amounts and labeled as an "energy blend." It is not clear whether these additional ingredients provide any physical or cognitive enhancement beyond that provided by caffeine alone. This article reviews the available empirical data on the interactive effects of these ingredients and caffeine on sleep and cognitive performance and suggests objectives for future study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Health effects of energy drinks on children, adolescents, and young adults
Seifert, S. M., Schaechter, J. L., Hershorin, E. R., & Lipshultz, S. E. (2011) · Pediatrics · doi:10.1542/peds.2009-3592 · Cited by 893
Effects of caffeine on human behavior
Smith, A. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00096-0 · Cited by 741
The effects of red bull energy drink on human performance and mood
Alford, C., Cox, H., & Wescott, R. (2001) · Amino Acids · doi:10.1007/s007260170021 · Cited by 403
l-theanine reduces psychological and physiological stress responses
Kimura, K., Ozeki, M., Juneja, L. R., & Ohira, H. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2006.06.006 · Cited by 349
Rae, C., Digney, A. L., McEwan, S. R., & Bates, T. C. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2003.2492 · Cited by 283
The Effects of L-Theanine, Caffeine and Their Combination on Cognition and Mood
Haskell, C. F., Kennedy, D. O., Milne, A. L., Wesnes, K. A., & Scholey, A. B. (2008) · Biological Psychology · doi:10.1016/j.biopsycho.2007.09.008 · Cited by 280
The Effect of Nitric-Oxide-Related Supplements on Human Performance
Bescós, R., Sureda, A., Tur, J. A., & Pons, A. (2012) · Sports Medicine · doi:10.2165/11596860-000000000-00000 · Cited by 231
Montgomery, S. A., Thal, L. J., & Amrein, R. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00001 · Cited by 209
Rogers, P. J., Smith, J. E., Heatherley, S. V., & Pleydell-Pearce, C. W. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0938-1 · Cited by 183
McMorris, T., Harris, R. C., Swain, J., Corbett, J., Collard, K., Dyson, R. J., Dye, L., Hodgson, C., & Draper, N. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0269-z · Cited by 168
Research works printed but not linked: 146
- Geiß, 1994, The effect of a taurine-containing drink on performance in 10 endurance-athletes, Amino Acids, 7, 45, 10.1007/BF00808445 · DOI
- Kennedy, 2004, A glucose-caffeine “energy drink” ameliorates subjective and performance deficits during prolonged cognitive demand, Appetite, 42, 331, 10.1016/j.appet.2004.03.001 · DOI
- Scholey, 2004, Cognitive and physiological effects of an “energy drink”: an evaluation of the whole drink and of glucose, caffeine and herbal flavouring fractions, Psychopharmacology, 176, 320, 10.1007/s00213-004-1935-2 · DOI · Paper page
- Seidl, 2000, A taurine and caffeine-containing drink stimulates cognitive performance and well-being, Amino Acids, 19, 635, 10.1007/s007260070013 · DOI · Paper page
- Smit, 2004, Mood and cognitive performance effects of “energy” drink constituents: caffeine, glucose and carbonation, Nutr Neurosci, 7, 127, 10.1080/10284150400003041 · DOI · Paper page
- Warburton, 2001, An evaluation of a caffeinated taurine drink on mood, memory and information processing in healthy volunteers without caffeine abstinence, Psychopharmacology, 158, 322, 10.1007/s002130100884 · DOI · Paper page
- Adan, 2010, Effects of caffeine and glucose, alone and combined, on cognitive performance, Hum Psychopharmacol, 25, 310, 10.1002/hup.1115 · DOI · Paper page
- Giles, 2012, Differential cognitive effects of energy drink ingredients: caffeine, taurine, and glucose, Pharmacol Biochem Behav, 102, 569, 10.1016/j.pbb.2012.07.004 · DOI · Paper page
- Maridakis, 2009, Sensitivity to change in cognitive performance and mood measures of energy and fatigue in response to morning caffeine alone or in combination with carbohydrate, Int J Neurosci, 119, 1239, 10.1080/00207450802333987 · DOI · Paper page
- Serra-Grabulosa, 2010, Glucose and caffeine effects on sustained attention: an exploratory fMRI study, Hum Psychopharmacol, 25, 543, 10.1002/hup.1150 · DOI
- Young, 2013, Caffeine can decrease subjective energy depending on the vehicle with which it is consumed and when it is measured, Psychopharmacology, 228, 243, 10.1007/s00213-013-3025-9 · DOI
- Peacock, 2013, Energy drink ingredients. Contribution of caffeine and taurine to performance outcomes, Appetite, 64, 1, 10.1016/j.appet.2012.12.021 · DOI
- Aggarwal, 2011, Effect of caffeine and taurine on simulated laparoscopy performed following sleep deprivation, Br J Surg, 98, 1666, 10.1002/bjs.7600 · DOI
- Kennedy, 2004, Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng, Pharmacol Biochem Behav, 79, 401, 10.1016/j.pbb.2004.07.014 · DOI · Paper page
- Benton, 2002, Carbohydrate ingestion, blood glucose and mood, Neurosci Biobehav Rev, 26, 293, 10.1016/S0149-7634(02)00004-0 · DOI · Paper page
- Gorby, 2010, Do specific dietary constituents and supplements affect mental energy? Review of the evidence, Nutr Rev, 68, 697, 10.1111/j.1753-4887.2010.00340.x · DOI
- Pizziol, 1998, Effects of caffeine on glucose tolerance: a placebo-controlled study, Eur J Clin Nutr, 52, 846, 10.1038/sj.ejcn.1600657 · DOI
- Nobre, 2008, L-theanine, a natural constituent in tea, and its effect on mental state, Asia Pac J Clin Nutr, 17, 167
- D'Angelo, 1986, A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers, J Ethnopharmacol, 16, 15, 10.1016/0378-8741(86)90063-2 · DOI
- Kennedy, 2001, Dose dependent changes in cognitive performance and mood following acute administration of Ginseng to healthy young volunteers, Nutr Neurosci, 4, 295, 10.1080/1028415X.2001.11747370 · DOI · Paper page
- Kennedy, 2002, Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults, Physiol Behav, 75, 739, 10.1016/S0031-9384(02)00665-0 · DOI
- Reay, 2005, Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity, J Psychopharmacol, 19, 357, 10.1177/0269881105053286 · DOI · Paper page
- Reay, 2006, Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained “mentally demanding” tasks, J Psychopharmacol, 20, 771, 10.1177/0269881106061516 · DOI · Paper page
- Scholey, 2002, Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand, Hum Psychopharmacol, 17, 35, 10.1002/hup.352 · DOI · Paper page
- Sorensen, 1996, A double-masked study of the effects of ginseng on cognitive functions, Curr Ther Res, 57, 959, 10.1016/S0011-393X(96)80114-7 · DOI
- Neale, 2013, Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes, Br J Clin Pharmacol, 75, 728, 10.1111/bcp.12002 · DOI · Paper page
- Henman, 1982, Guarana (Paullinia cupana var. sorbilis): ecological and social perspectives on an economic plant of the central Amazon basin, J Ethnopharmacol, 6, 311, 10.1016/0378-8741(82)90054-X · doi:10.1016/0378-8741(82)90054-x
- Haskell, 2013, Behavioural effects of compounds co-consumed in dietary forms of caffeinated plants, Nutr Res Rev, 26, 49, 10.1017/S0954422413000036 · DOI
- McLellan, 2012, Do energy drinks contain active components other than caffeine?, Nutr Rev, 70, 730, 10.1111/j.1753-4887.2012.00525.x · DOI · Paper page
- Haskell, 2007, A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guaraná in humans, J Psychopharmacol, 21, 65, 10.1177/0269881106063815 · DOI · Paper page
- Kennedy, 2008, Improved cognitive performance and mental fatigue following a multi-vitamin and mineral supplement with added guaraná (Paullinia cupana), Appetite, 50, 506, 10.1016/j.appet.2007.10.007 · DOI
- Silvestrini, 2013, Effects of a commercial product containing guarana on psychological well-being, anxiety and mood: a single-blind, placebo-controlled study in healthy subjects, J Negat Results Biomed, 12, 9, 10.1186/1477-5751-12-9 · DOI
- Costa Miranda, 2009, Effectiveness of guaraná (Paullinia cupana) for postradiation fatigue and depression: results of a pilot double-blind randomized study, J Altern Complement Med, 15, 431, 10.1089/acm.2008.0324 · DOI
- Oliveira Campos, 2011, Guaraná (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy, J Altern Complement Med, 17, 505, 10.1089/acm.2010.0571 · DOI · Paper page
- Galduróz, 1994, Acute effects of the Paulinia cupana, “Guaraná” on the cognition of normal volunteers, Sao Paulo Med J, 112, 607, 10.1590/S1516-31801994000300007 · doi:10.1590/s1516-31801994000300007
- Galduróz, 1996, The effects of long-term administration of guarana on the cognition of normal, elderly volunteers, Sao Paulo Med J, 114, 1073, 10.1590/S1516-31801996000100003 · doi:10.1590/s1516-31801996000100003
- Banderet, 1989, Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans, Brain Res Bull, 22, 759, 10.1016/0361-9230(89)90096-8 · DOI · Paper page
- Deijen, 1994, Effect of tyrosine on cognitive function and blood pressure under stress, Brain Res Bull, 33, 319, 10.1016/0361-9230(94)90200-3 · DOI
- Deijen, 1999, Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course, Brain Res Bull, 48, 203, 10.1016/S0361-9230(98)00163-4 · DOI
- Dollins, 1995, L-tyrosine ameliorates some effects of lower body negative pressure stress, Physiol Behav, 57, 223, 10.1016/0031-9384(94)00278-D · DOI
- Neri, 1995, The effects of tyrosine on cognitive performance during extended wakefulness, Aviat Space Environ Med, 66, 313
- Shukitt-Hale, 1996, Tyrosine administration prevents hypoxia-induced decrements in learning and memory, Physiol Behav, 59, 867, 10.1016/0031-9384(95)02107-8 · DOI
- Amieva, 2013, Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study, PLoS ONE, 8, e52755, 10.1371/journal.pone.0052755 · DOI
- Andrieu, 2003, Association of Alzheimer's disease onset with Ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study, J Gerontol A Biol Sci Med Sci, 58, 372, 10.1093/gerona/58.4.M372 · DOI
- Herrschaft, 2012, Ginkgo biloba extract EGb 761(R) in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg, J Psychiatr Res, 46, 716, 10.1016/j.jpsychires.2012.03.003 · DOI · Paper page
- Ihl, 2010, Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761[R]) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial, J Neurol Sci, 299, 184, 10.1016/j.jns.2010.08.033 · DOI
- Schneider, 2005, A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type, Curr Alzheimer Res, 2, 541, 10.2174/156720505774932287 · DOI · Paper page
- DeKosky, 2008, Ginkgo biloba for prevention of dementia: a randomized controlled trial, JAMA, 300, 2253, 10.1001/jama.2008.683 · DOI · Paper page
- Dodge, 2008, A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline, Neurology, 70, 1809, 10.1212/01.wnl.0000303814.13509.db · DOI · Paper page
- Vellas, 2012, Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial, Lancet Neurol, 11, 851, 10.1016/S1474-4422(12)70206-5 · DOI · Paper page
- Weinmann, 2010, Effects of Ginkgo biloba in dementia: systematic review and meta-analysis, BMC Geriatr, 10, 14, 10.1186/1471-2318-10-14 · DOI · Paper page
- Birks, 2007, Ginkgo biloba for cognitive impairment and dementia, Cochrane Database Syst Rev, 10.1002/14651858.CD003120.pub2 · DOI
- Canter, 2007, Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people, Hum Psychopharmacol, 22, 265, 10.1002/hup.843 · DOI
- Roland, 2012, Ginkgo biloba - effect, adverse events and drug interaction, Tidsskr Nor Laegeforen, 132, 956, 10.4045/tidsskr.11.0780 · DOI
- Kennedy, 2007, Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine, Hum Psychopharmacol, 22, 199, 10.1002/hup.837 · DOI
- Rigney, 1999, The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers, Phytother Res, 13, 408, 10.1002/(SICI)1099-1573(199908/09)13:5<408::AID-PTR530>3.0.CO;2-C · DOI · Paper page
- Kennedy, 2000, The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers, Psychopharmacology, 151, 416, 10.1007/s002130000501 · DOI · Paper page
- Kennedy, 2007, Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers, Hum Psychopharmacol, 22, 559, 10.1002/hup.885 · DOI · Paper page
- Itil, 1996, Central nervous system effects of Ginkgo biloba, a plant extract, Am J Ther, 3, 63, 10.1097/00045391-199601000-00009 · DOI
- Kennedy, 2003, Electroencephalograph effects of single doses of Ginkgo biloba and Panax ginseng in healthy young volunteers, Pharmacol Biochem Behav, 75, 701, 10.1016/S0091-3057(03)00120-5 · DOI
- Ozgoli, 2009, A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome, J Altern Complement Med, 15, 845, 10.1089/acm.2008.0493 · doi:10.1089/acm.2008.0493
- Hartley, 2003, Effects on cognition and mood in postmenopausal women of 1-week treatment with Ginkgo biloba, Pharmacol Biochem Behav, 75, 711, 10.1016/S0091-3057(03)00123-0 · DOI
- Cockle, 2000, The effects of Ginkgo biloba extract (LI 1370) supplementation on activities of daily living in free living older volunteers: a questionnaire survey, Hum Psychopharmacol, 15, 227, 10.1002/1099-1077(200006)15:4<227::AID-HUP208>3.0.CO;2-M · DOI
- Soholm, 1998, Clinical improvement of memory and other cognitive functions by Ginkgo biloba: review of relevant literature, Adv Ther, 15, 54
- Stough, 2001, Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants, Int J Neuropsychopharmacol, 4, 131, 10.1017/S1461145701002292 · DOI · Paper page
- Kaschel, 2009, Ginkgo biloba: specificity of neuropsychological improvement - a selective review in search of differential effects, Hum Psychopharmacol, 24, 345, 10.1002/hup.1037 · DOI · Paper page
- Zadoyan, 2012, Effect of Ginkgo biloba special extract EGb 761(R) on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers, Eur J Clin Pharmacol, 68, 553, 10.1007/s00228-011-1174-5 · DOI
- Baggott, 2013, Psychopharmacology of theobromine in healthy volunteers, Psychopharmacology, 228, 109, 10.1007/s00213-013-3021-0 · DOI
- Mumford, 1994, Discriminative stimulus and subjective effects of theobromine and caffeine in humans, Psychopharmacology, 115, 1, 10.1007/BF02244744 · DOI
- Smit, 2004, Methylxanthines are the psycho-pharmacologically active constituents of chocolate, Psychopharmacology, 176, 412, 10.1007/s00213-004-1898-3 · DOI
- Bartel, 1992, Effects of single and repeated doses of theophylline on aspects of performance, electrophysiology and subjective assessments in healthy human subjects, Psychopharmacology, 106, 90, 10.1007/BF02253594 · DOI
- Tiplady, 1990, A comparison of the CNS effects of enprofylline and theophylline in healthy subjects assessed by performance testing and subjective measures, Br J Clin Pharmacol, 30, 55, 10.1111/j.1365-2125.1990.tb03743.x · DOI
- Yu, 1991, A comparison of the central nervous system effects of caffeine and theophylline in elderly subjects, Br J Clin Pharmacol, 32, 341, 10.1111/j.1365-2125.1991.tb03909.x · DOI
- Nehlig, 2013, The neuroprotective effects of cocoa flavanol and its influence on cognitive performance, Br J Clin Pharmacol, 75, 716, 10.1111/j.1365-2125.2012.04378.x · DOI · Paper page
- Macready, 2009, Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies, Genes Nutr, 4, 227, 10.1007/s12263-009-0135-4 · DOI · Paper page
- Young, 2007, Folate and depression - a neglected problem, J Psychiatry Neurosci, 32, 80
- Young, 1989, Folic acid and psychopathology, Prog Neuropsychopharmacol Biol Psychiatry, 13, 841, 10.1016/0278-5846(89)90037-7 · DOI
- Falkingham, 2010, The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis, Nutr J, 9, 4, 10.1186/1475-2891-9-4 · DOI · Paper page
- Vinod Kumar, 2008, Trial using multiple micronutrient food supplement and its effect on cognition, Indian J Pediatr, 75, 671, 10.1007/s12098-008-0127-1 · DOI
- Bryan, 2004, Associations between dietary intake of folate and vitamins B-12 and B-6 and self-reported cognitive function and psychological well-being in Australian men and women in midlife, J Nutr Health Aging, 8, 226
- Deijen, 1992, Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort, Psychopharmacology, 109, 489, 10.1007/BF02247729 · DOI
- Bryan, 2002, Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages, J Nutr, 132, 1345, 10.1093/jn/132.6.1345 · DOI · Paper page
- Haskell, 2010, Effects of a multi-vitamin/mineral supplement on cognitive function and fatigue during extended multi-tasking, Hum Psychopharmacol, 25, 448, 10.1002/hup.1144 · DOI · Paper page
- Malouf, 2008, Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD004514.pub2 · DOI · Paper page
- Zhang, 2011, Vitamin C provision improves mood in acutely hospitalized patients, Nutrition, 27, 530, 10.1016/j.nut.2010.05.016 · DOI
- Chui, 2008, Antioxidant vitamins reduce acute meal-induced memory deficits in adults with type 2 diabetes, Nutr Res, 28, 423, 10.1016/j.nutres.2008.03.016 · DOI
- Dixon, 1997, Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release, J Neurotrauma, 14, 161, 10.1089/neu.1997.14.161 · DOI · Paper page
- Petkov, 1990, Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats), Gen Pharmacol, 21, 71, 10.1016/0306-3623(90)90598-G · DOI
- Alvarez, 1997, Citicoline improves memory performance in elderly subjects, Methods Find Exp Clin Pharmacol, 19, 201
- Di Trapani, 1991, Citicoline in the treatment of cognitive and behavioral disorders in pathologic senile decline, Clin Ter, 137, 403
- Spiers, 1996, Citicoline improves verbal memory in aging, Arch Neurol, 53, 441, 10.1001/archneur.1996.00550050071026 · DOI · Paper page
- Fioravanti, 2006, Citicoline (Cognizin) in the treatment of cognitive impairment, Clin Interv Aging, 1, 247, 10.2147/ciia.2006.1.3.247 · DOI
- Bruce, 2012, Improvements in quantitative EEG following consumption of a natural citicoline-enhanced beverage, Int J Food Sci Nutr, 63, 421, 10.3109/09637486.2011.632623 · DOI
- Silveri, 2008, Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy, NMR Biomed, 21, 1066, 10.1002/nbm.1281 · DOI
- Cynober, 2007, Pharmacokinetics of arginine and related amino acids, J Nutr, 137, 1646S, 10.1093/jn/137.6.1646S · DOI
- McConell, 2007, Effects of L-arginine supplementation on exercise metabolism, Curr Opin Clin Nutr Metab Care, 10, 46, 10.1097/MCO.0b013e32801162fa · DOI · Paper page
- Paul, 2003, Prevention of picrotoxin convulsions-induced learning and memory impairment by nitric oxide increasing dose of L-arginine in rats, Pharmacol Biochem Behav, 75, 329, 10.1016/S0091-3057(03)00084-4 · DOI
- Paul, 2005, A reversal by L-arginine and sodium nitroprusside of ageing-induced memory impairment in rats by increasing nitric oxide concentration in the hippocampus, Indian J Physiol Pharmacol, 49, 179
- Ohtsuka, 2000, Effect of oral administration of L-arginine on senile dementia, Am J Med, 108, 439, 10.1016/S0002-9343(99)00396-4 · DOI
- Yi, 2009, L-arginine and Alzheimer's disease, Int J Clin Exp Pathol, 2, 211
- Khan, 2013, Tea and health: studies in humans, Curr Pharm Des, 19, 6141, 10.2174/1381612811319340008 · DOI · Paper page
- Song, 2012, Tea and cognitive health in late life: current evidence and future directions, J Nutr Health Aging, 16, 31, 10.1007/s12603-011-0139-9 · DOI · Paper page
- Malaguarnera, 2012, Carnitine derivatives: clinical usefulness, Curr Opin Gastroenterol, 28, 166, 10.1097/MOG.0b013e3283505a3b · DOI
- Malaguarnera, 2013, Acetyl-L-carnitine in hepatic encephalopathy, Metab Brain Dis, 28, 193, 10.1007/s11011-013-9376-4 · DOI
- Tempesta, 1987, L-acetylcarnitine in depressed elderly subjects. A cross-over study versus placebo, Drugs Exp Clin Res, 13, 417
- Birdsall, 1998, 5-Hydroxytryptophan: a clinically-effective serotonin precursor, Altern Med Rev, 3, 271
- Meyers, 2000, Use of neurotransmitter precursors for treatment of depression, Altern Med Rev, 5, 64
- Zmilacher, 1988, L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression, Neuropsychobiology, 20, 28, 10.1159/000118469 · DOI
- Lynn-Bullock, 2004, The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats, J Chem Neuroanat, 27, 129, 10.1016/j.jchemneu.2004.02.003 · DOI
- Okada, 2009, Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms, Arthritis Rheum, 61, 1305, 10.1002/art.24460 · doi:10.1002/art.24460
- Turner, 2006, Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan, Pharmacol Ther, 109, 325, 10.1016/j.pharmthera.2005.06.004 · DOI · Paper page
- Gendle, 2010, Oral administration of 5-hydroxytryptophan (5-HTP) impairs decision making under ambiguity but not under risk: evidence from the Iowa Gambling Task, Hum Psychopharmacol, 25, 491, 10.1002/hup.1139 · DOI
- Gijsman, 2002, Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers, J Clin Psychopharmacol, 22, 183, 10.1097/00004714-200204000-00012 · DOI · Paper page
- Cunliffe, 1998, A placebo-controlled investigation of the effects of tryptophan or placebo on subjective and objective measures of fatigue, Eur J Clin Nutr, 52, 425, 10.1038/sj.ejcn.1600581 · DOI
- Gendle, 2013, Effects of oral 5-hydroxytryptophan on a standardized planning task: insight into possible dopamine/serotonin interactions in the forebrain, Hum Psychopharmacol, 28, 270, 10.1002/hup.2314 · DOI
- Alves, 1995, Effects of caffeine and tryptophan on rectal temperature, metabolism, total exercise time, rate of perceived exertion and heart rate, Braz J Med Biol Res, 28, 705
- Kasper, 2008, Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials, Eur Arch Psychiatry Clin Neurosci, 258, 59, 10.1007/s00406-007-0779-2 · DOI
- Linde, 1996, St John's wort for depression - an overview and meta-analysis of randomised clinical trials, BMJ, 313, 253, 10.1136/bmj.313.7052.253 · DOI · Paper page
- Brenner, 2000, Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study, Clin Ther, 22, 411, 10.1016/S0149-2918(00)89010-4 · DOI · Paper page
- Schrader, 2000, Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression, Int Clin Psychopharmacol, 15, 61, 10.1097/00004850-200015020-00001 · DOI · Paper page
- Wheatley, 1997, LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial, Pharmacopsychiatry, 30, 77, 10.1055/s-2007-979523 · DOI
- Woelk, 2000, Comparison of St John's wort and imipramine for treating depression: randomised controlled trial, BMJ, 321, 536, 10.1136/bmj.321.7260.536 · DOI · Paper page
- Ernst, 1999, Second thoughts about safety of St John's wort, Lancet, 354, 2014, 10.1016/S0140-6736(99)00418-3 · DOI · Paper page
- Russo, 2014, Hypericum perforatum: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug-Drug Interactions, Phytother Res, 28, 643, 10.1002/ptr.5050 · DOI · Paper page
- Butterweck, 2003, Mechanism of action of St John's wort in depression: what is known?, CNS Drugs, 17, 539, 10.2165/00023210-200317080-00001 · DOI · Paper page
- Chatterjee, 1998, Hyperforin as a possible antidepressant component of Hypericum extracts, Life Sci, 63, 499, 10.1016/S0024-3205(98)00299-9 · DOI · Paper page
- Chatterjee, 1998, Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility, Pharmacopsychiatry, 31, 7, 10.1055/s-2007-979340 · DOI · Paper page
- Muller, 1997, Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity, Pharmacopsychiatry, 30, 102, 10.1055/s-2007-979528 · DOI · Paper page
- Wonnemann, 2000, Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways, Neuropsychopharmacology, 23, 188, 10.1016/S0893-133X(00)00102-0 · DOI
- Ellis, 2001, An investigation into the acute nootropic effects of Hypericum perforatum L. (St. John's Wort) in healthy human volunteers, Behav Pharmacol, 12, 173, 10.1097/00008877-200105000-00003 · DOI
- Timoshanko, 2001, A preliminary investigation on the acute pharmacodynamic effects of hypericum on cognitive and psychomotor performance, Behav Pharmacol, 12, 635, 10.1097/00008877-200112000-00008 · DOI
- Arold, 2005, No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract, Planta Med, 71, 331, 10.1055/s-2005-864099 · DOI · Paper page
- Charney, 1985, Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment, Arch Gen Psychiatry, 42, 458, 10.1001/archpsyc.1985.01790280040004 · DOI
- Halliday, 1994, The effect of d-amphetamine, clonidine, and yohimbine on human information processing, Psychophysiology, 31, 331, 10.1111/j.1469-8986.1994.tb02441.x · DOI · Paper page
- Mizuki, 1996, Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety, Prog Neuropsychopharmacol Biol Psychiatry, 20, 1353, 10.1016/S0278-5846(96)00131-5 · DOI
- Kearney, 2010, Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases, Ann Pharmacother, 44, 1022, 10.1345/aph.1P060 · DOI
- Heck, 2007, Yerba Mate tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations, J Food Sci, 72, R138, 10.1111/j.1750-3841.2007.00535.x · DOI · Paper page
- Bonoczk, 2002, Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study, Eur J Ultrasound, 15, 85, 10.1016/S0929-8266(02)00006-X · DOI
- Patyar, 2011, Role of vinpocetine in cerebrovascular diseases, Pharmacological Reports, 63, 618, 10.1016/S1734-1140(11)70574-6 · DOI
- Brown, 2013, Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine, Med J Aust, 198, 414, 10.5694/mja12.11167 · doi:10.5694/mja12.11167
- Eliason, 2012, Case reports: death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA), Mil Med, 177, 1455, 10.7205/MILMED-D-12-00265 · DOI · Paper page
- Lieberman, 2006, Mental energy: assessing the cognition dimension, Nutr Rev, 64, S10, 10.1111/j.1753-4887.2006.tb00252.x · DOI
- O'Connor, 2006, Mental energy: assessing the mood dimension, Nutr Rev, 64, S7, 10.1111/j.1753-4887.2006.tb00256.x · DOI · Paper page
- O'Connor, 2006, Mental energy: developing a model for examining nutrition-related claims, Nutr Rev, 64, S2, 10.1111/j.1753-4887.2006.tb00255.x · DOI
- Arria, 2011, Energy drink consumption and increased risk for alcohol dependence, Alcohol Clin Exp Res, 35, 365, 10.1111/j.1530-0277.2010.01352.x · DOI · Paper page
- Arria, 2010, Increased alcohol consumption, nonmedical prescription drug use, and illicit drug use are associated with energy drink consumption among college students, J Addict Med, 4, 74, 10.1097/ADM.0b013e3181aa8dd4 · DOI · Paper page
Cited by
Vitamin D testing and treatment: a narrative review of current evidence
Pilz, S., Zittermann, A., Trummer, C., Theiler-Schwetz, V., Lerchbaum, E., Keppel, M. H., Grübler, M. R., März, W., & Pandis, M. (2019) · Endocrine Connections · doi:10.1530/ec-18-0432 · Cited by 276
Souza, D. B., Del Coso, J., Casonatto, J., & Polito, M. D. (2017) · European Journal of Nutrition · doi:10.1007/s00394-016-1331-9 · Cited by 169
Miles-Chan, J. L., Charrière, N., Grasser, E. K., Montani, J.-P., & Dulloo, A. G. (2015) · Physiological Reports · doi:10.14814/phy2.12290 · Cited by 42
“The research which has been undertaken is often focused on sport or cognitive performance (for reviews, see Mora-Rodriguez and Pallares 2014; Childs 2014), lacks tight control of food and beverage consumption prior to testing (Franks et al.”
Marmorstein, N. R. (2016) · Journal of Caffeine Research · doi:10.1089/jcr.2015.0018 · Cited by 34
A systematic review and meta-analysis of the acute effect of caffeine on attention
Kløve, K., & Petersen, A. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06775-1 · Cited by 10
“Studies have demonstrated that caffeine has a beneficial effect on mood, physical performance, wakefulness, and several aspects of cognition (Ruxton 2008; Koppelstaetter et al. 2010; Childs 2014; McLellan et al. 2016).”
Metadata
- Authors
- Childs, E.
- Venue
- Nutrition Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10
- Volume
- 72
- Pages
- 48-59
- ISSN
- 0029-6643 (ISSN-L)
- OpenAlex
- W2079261072
- Cited by
- 48
- References
- 30
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Influence of energy drink ingredients on mood and cognitive performance. https://app.cochat.ai/papers/10.1111/nure.12148
- The paper
- Childs, E. (2014). Influence of energy drink ingredients on mood and cognitive performance. Nutrition Reviews. https://doi.org/10.1111/nure.12148
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.